Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Grab Holdings Ltd. (GRAB) vs Smith & Nephew plc (SNN) Price & Performance

Grab Holdings Ltd.Trade
Smith & Nephew plcTrade

Price performance (Past 24H)

Key statistics

Grab Holdings Ltd. vs Smith & Nephew plc — how do they compare? Grab Holdings Ltd. trades at $3.19 (market cap $12.72B), while Smith & Nephew plc trades at $27.21 (market cap $11.10B). The key difference: Grab Holdings Ltd. and Smith & Nephew plc are close in size by market cap, and Smith & Nephew plc pays a 2.95% dividend while Grab Holdings Ltd. pays none. Which is the better fit depends on your goals — on Pluang, investors hold Grab Holdings Ltd. for 94 Days and Smith & Nephew plc for 121 Days on average.

GRABSNN
Market Cap
$12.72B$11.10B
Volume
65,352,8591,051,703
Sector
TechnologyHealth
52-Week High
$6.17$37.17
52-Week Low
$2.80$26.42
Typical Hold Time
94 Days121 Days
Enterprise Value
$8.46B$14.13B
Dividend Yield
—2.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Grab Holdings Ltd.

Grab Holdings (GRAB) trades at $3.195, up 3.73% today, showing strong momentum after recent volatility. The stock demonstrates improving fundamentals with revenue growing from $2.8B in 2024 to $3.37B in 2025 and achieving profitability with $268M net income. Recent Q2 2026 earnings beat expectations with $0.06 EPS versus $0.05 expected, while technical indicators show bearish signals despite neutral oscillators. The company's $1.49B acquisition of Atome Financial positions it for financial services expansion.

Grab presents a compelling turnaround story with accelerating revenue growth and recent profitability. The strong analyst consensus (91.67% buy ratings) and $30M CEO share purchase signal confidence, though technical weakness and competitive pressures in Southeast Asia's ride-hailing market warrant caution. Key catalysts include continued execution on profitability targets and successful integration of Atome acquisition.

Smith & Nephew plc

SNN trades at $27.10, near its 52-week low, with a bearish technical signal. The company reported solid fundamentals with revenue growth to $6.16B in 2025 and a net income margin of 10.08%. Recent product launches, like the EVOS PELVIC System, aim to strengthen its medical technology portfolio. Cash flow from operations remains strong at $1.29B, though net cash flow was negative $64M in 2025.

The outlook is mixed: strong profitability and innovation support long-term value, but near-term headwinds include analyst downgrades and competitive pressures. Risks involve execution challenges and market sentiment. The stock presents a cautious opportunity for value investors, balancing solid fundamentals against current bearish trends.

Returns comparison

Trailing returns across standard periods

Investor sentiment on Pluang

What Pluang investors did over the last 30 days

GRAB
24% Buy76% Sell
Avg holding period · 94 Days
SNN

No sentiment data available yet.

Top news

Latest headlines on both assets

About Grab Holdings Ltd.

Grab Holdings Limited operates as a holding company. The Company, through its subsidiaries, develops delivery management, mobility, financial services, and enterprise software solutions. Grab Holdings serves customers worldwide.

Read more on GRAB →

About Smith & Nephew plc

Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound-care solutions. Roughly 42% of the U.K.-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 28% of revenue is from the advanced wound therapy segment. Roughly half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.

Read more on SNN →